Apollo Endosurgery, CSA Medical & more — 3 GI company key notes

Here are three updates on GI companies from the past week:

The FDA awarded Apollo Endosurgery's OverStitch Sx system FDA 510(k) clearance.

The FDA granted Ferring Pharmaceuticals approval to market Clenpiq, an oral solution for colon preparation.

CSA Medical announced the enrollment of the first patient into a multicenter study evaluating its spray cryotherapy on esophageal cancer patients. The patient was treated at Chapel Hill-based University of North Carolina's Center for Esophageal Diseases and Swallowing.

More articles on gastroenterology:
9 GI leaders to know for November
Stock market week-in-review for 5 large GI companies — Nov. 20-24
6 insights into Crohn's on a global level — US has 993k cases

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months